|
|
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.United States |
First Approval Date15 Aug 2025 |
100 Clinical Results associated with North American Genomics LLC
0 Patents (Medical) associated with North American Genomics LLC
100 Deals associated with North American Genomics LLC
100 Translational Medicine associated with North American Genomics LLC